Galectin-3 production has been observed to be elevated or increased in inflammatory and fibrotic processes, as seen in liver disease [13,16]. Galectin-3 is upregulated in cirrhotic livers, especially in the regenerative nodules. This evidence concerns the gene LGALS3 and liver disorder.